Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 49.81 Delayed Data As of 4:00pm ET |  -1.46 / -2.85%Today’s Change | 38.40 Today|||52-Week Range 58.59 | +18.31% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 21.7M | 16.6M | 65.7M | 63.9M | |
| Short Term Investment Cash | -9.0M | -5.1M | 49.1M | -1.8M | ||
| Cash & Short Term Investments | 145.2M | 210.1M | 223.7M | 308.7M | ||
| Receivables | Receivables | 15.7M | 12.8M | 10.6M | 67.2M | |
| Inventories | Inventories | -- | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 9.7M | 9.2M | 3.5M | 4.5M | |
| Current Assets | 170.6M | 232.2M | 237.8M | 380.4M | ||
| Total Assets | Property, Plant and Equipment - Gross | 10.2M | 13.1M | 15.1M | 17.5M | |
| Depreciation | -4.3M | -5.1M | -7.1M | -9.1M | ||
| Other Assets | 0.00 | 0.00 | 0.00 | 92.0K | ||
| Total Assets | 246.0M | 281.4M | 327.9M | 415.2M | ||
| Liabilities | Accounts Payable | 1.5M | 3.4M | 3.7M | 4.7M | |
| Short Term Debt | 69.0K | 73.0K | 79.0K | 0.00 | ||
| Accrued Expenses | 964.0K | 2.1M | 5.1M | 6.6M | ||
| Other Current Liabilities | 2.3M | 2.1M | 5.1M | 6.6M | ||
| Other Liabilities | 6.7M | 7.9M | 21.0M | 16.0M | ||
| Total Liabilities | Long Term Debt | 692.0K | 617.0K | 1.1M | 1.9M | |
| Deferred Taxes | -4.6M | -8.4M | -10.1M | -8.4M | ||
| Other Liabilities | 1.9M | 1.9M | 1.5M | 593.0K | ||
| Total Liabilities | 9.9M | 11.4M | 26.2M | 21.5M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 236.2M | 269.9M | 301.7M | 393.7M | ||
| Total Shareholder Equity | 236.2M | 269.9M | 301.7M | 393.7M | ||
| Share Information | Common Shares Outstanding | 18.7M | 19.0M | 19.1M | 19.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
